Getting Science Papers Published: Where It's Easy, Where It's Not

Chemists, astronomers, or physicists looking to publish in one of their discipline's scholarly journals stand a far better chance of having their submissions accepted first time around than do anthropologists, psychologists, or sociologists. This conclusion combs from independently undertaken studies reported on earlier this year, which found that, in general, journals dedicated to physical sciences have markedly lower rejection rates than do publications geared toward the social sciences. One o

Written byChristopher Anderson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

One of the studies—reported on in the American Sociological Review (volume 53, pages 139-51)—claims, for example, that some chemical journals reject only 15% to 20% of papers submitted; on the other hand, the ASR report points out, an important political science journal—the American Political Science Review—has been known to reject as many as 94% of its submissions over a period of time. Meanwhile, another study—reported on in Publications of the Astronomical Society of the Pacific (volume 100, number 626, pages 506-08)—concurs in observing the disparity, comparing relatively low acceptance rates at social science journals with, for example, three major astronomical journals that accept more than 90% of the manuscripts submitted to them.

The reason for the disparity?

According to Lowell Hargens, a University of Illinois sociologist who wrote the ASR study, physical scientists more often put their papers through several review steps—beginning with grant applications and including informal reviews by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies